Refine by
Patient Selection Articles & Analysis
24 articles found
It can be performed year-round and integrates with other Sciton treatments, making it suitable for maintenance throughout the weight-loss process.ClearSilk offers a gentle, no-downtime entry point for patients new to lasers or preferring a lighter approach. Known as the lunchtime facial, it softens fine lines, improves texture, and reduces redness, pigmented lesions, and flushing ...
Marrying this approach with the ability to deploy a biomarker-based strategy for selecting targeted patient cohorts can significantly derisk the clinical trial process ...
Clinical trials are the backbone of modern medicine, responsible for bringing innovative, safe, and efficient treatments to market after rigorous testing and evaluation. However, the conventional process of conducting these trials has often been long, expensive, and fraught with inefficiencies¹. The advent of predictive analytics is reshaping the landscape of clinical trials, ushering in a ...
Dr. Kate Sasser from Tempus led a discussion on the potential of antibody-drug conjugates (ADCs), their challenges in targeting tumor antigens, and the future of cancer treatment with Dr. Daniel Johnson, Dr. Funda Meric-Bernstam, and Dr. Kellogg Parsons. The oncology field is rapidly advancing with the development of antibody-drug conjugates (ADCs), offering new hope for ...
ByTempus
A user had to be able to easily navigate between samples, the source of the samples (patients) and the storage area. This would enable questions such as “show me all the samples for a given patient” or “show me where in the container a specific sample is” to be answered. ...
It can aid in the identification of biomarkers for patient stratification, allowing for more precise targeting of patient populations most likely to respond to a particular treatment. ...
Profiling patient samples using scRNA-seq helps identify cell types relevant to the disease and develop more accurate disease models. ...
During the webinar, you’ll learn about: Treatment options and unmet needs of HFrEF patients The physiologic rationale of baroreflex activation Barostim therapy overview and clinical evidence overview Appropriate patient selection and real-world experience Important Safety Information CAUTION: Federal ...
ByCVRx
We also discuss challenges posed in clinical trial design for these novel device–based strategies including optimal patient selection and appropriate end points to establish efficacy. ...
Current guidelines recommend adjuvant treatment only for selected patients with stage II or higher disease. A prediction model that identifies patients at high risk of recurrence who may benefit from adjuvant treatment is greatly needed. ...
Materials and Methods We analyzed gene expression in frozen lung cancer tissue from 59 selected patients who had undergone surgical resection of NSCLC. These patients were divided into two groups: group R, patients who had a tumor recurrence within four years, n=37; group NR, patients who remained disease-free ...
As an orthotics and prosthetics practice, attracting and retaining patients can be challenging. While there are millions of limb loss patients around the world, they may all be searching for different solutions. Consequently, it’s important to showcase your professional talents as a clinician as well as offer custom solutions to your patients’ needs. But, not to worry. We’ve ...
While the approaches differ, the overarching goal is often the same: bring better medicines to patients with less failure. I was particularly excited to see the variety of perspectives represented - not only from AI-powered companies like Recursion, but also large pharma companies, academics and investors. ...
In Figure 1, is possible to see the new design, in the top, is visible the status of platform, if it is connected or not, and also if exists one patient selected. Then the interface is divided in two main areas. Left area has the steps of the protocol, the timer and the buttons to start, pause, stop or save and export data. ...
Our frustration is shared by the doctor, who has had success with that procedure or drug on patients just like us. Medical device companies are in the middle of this. ...
ByRestech
Clinical operations executive leaders within these companies can use this planning process to make investments that address common barriers to achieving their department’s goals: Lack of sufficient resources Incomplete data aggregation Inadequate technology support These problems are often related and represent different aspects of the same issue – inefficient processes and ...
On the other hand, most of my patients are haphazardly self-selecting supplements. In many cases, prescribing a specific formulation saves them money and ends up being less to swallow—literally. Talk to Patients About AMDQ: How do your patients react when you tell them you want to test them for AMD? ...
The mCTSIB, LOS, RWS, WBS, STS, US, Fall Risk and TBP protocols have normative values according to the patient’s age. For these protocols, except Fall Risk, the normative values are for patients in the age group of 20 to 79 years. While the Fall Risk is for patients over the age of 50 years. At the end of each protocol an interface with ...
Methods: Hip DXA images from a subset of randomly selected patients in the ACTIVE trial (n = 250/arm) were retrospectively analyzed using three-dimensional modeling methods (3D-SHAPER software) to evaluate changes from baseline at months 6 and 18. ...
After seven years and 5,300-patients tested, the results of the landmark TAILOR-PCI trial were announced in a virtual ACC session. This trial investigated whether a prospective approach using rapid on-site CYP2C19 testing could improve patient outcomes when selecting P2Y12 inhibitor therapy following PCI procedure. ...